Alison Fethke Enhances the Firm’s Health Care and Life Sciences Regulatory Services to Clients and Chicago Market
Ropes & Gray announced today that Alison Fethke, past division counsel, legal regulatory & compliance at AbbVie, the pharmaceutical company resulting from the separation of Abbott Laboratories in 2012, is rejoining the firm as counsel in the Chicago office.
Ms. Fethke will bring her decade-long experience managing complex legal and regulatory matters in the health care and life sciences industries to the service of Ropes & Gray’s clients. She has provided regulatory advice on a wide range of issues, including health care and FDA compliance matters such as product registrations, Good Manufacturing Practices, clinical trials, advertising and promotion, and Corporate Integrity Agreement compliance.
“Alison’s breadth of experience will augment Ropes & Gray’s capabilities in the health care and life sciences industries for a wide range of companies, including pharmaceutical and medical device companies, health care providers and health plans, as well as private equity sponsors, particularly in Chicago and the Midwest,” said Deborah Gersh, a Chicago-based health care partner at Ropes & Gray. “Alison will provide strategic counsel to guide clients through a complex, consistently evolving health care landscape facing new regulatory compliance challenges.”
Ms. Fethke graduated cum laude from Duke University in 1997 and received her J.D. from New York University School of Law, cum laude, in 2000. She was a corporate associate at Ropes & Gray from 2000-2005.
Ropes & Gray is a leading global law firm with offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul.Ropes & Gray represents participants in virtually every sector of the health care industry, including academic medical centers, community hospitals, pharmaceutical companies, pharmacy benefit managers, managed care organizations and insurance companies, health care provider organizations, physician practice groups, health care technology and biomedical companies, and long-term care and skilled nursing home providers.